We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX health stocks fall 1.3% in past five days, while broader market is marginally up 0.7% Neuren s...
Read ArticleASX up, Xero leads gains Miners hit as iron ore drops, Variscan jumps 50pc Asian stocks down, Bitco...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleThe S&P/ASX 200 fell 1.3% in October with small cap companies outperforming S&P Dow Jones I...
Read ArticleASX opens November lower, led by financial sector sell-off Macquarie Group fell after profit decli...
Read ArticleASX health stocks fall 2.15% in past five days, while broader market down 1.42% MedAdvisor drops 3...
Read ArticleASX slips amid earnings updates and company meetings AGL drops over 6pc after downgrade, while...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleThe ASX ended higher after a slow start Energy stocks leading while telcos and miners lagged Asian...
Read ArticleClinuvel’s shares jump after reporting a $35.6 million profit for FY24 The company hits its eighth...
Read ArticleNvidia’s stock dropped despite strong earnings and future guidance SuperMicro shares fell over 19pc...
Read ArticleA cooperative research centre believes there is an opportunity to transform Australia’s healthcare...
Read ArticleASX health stocks rise 0.8% past five days as broader market lifts 3.7% Morgans says ProMedicus ‘p...
Read ArticleASX health stocks fall 0.37% over past five days in line with broader markets Cardiac company Imri...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleIt's been a decent start to both the month of July and the 2025 financial year for ASX shares so far...
Read ArticleASX health stocks fall 0.19% in past five days as broader markets lift 0.79% Morgans says capital r...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleTesltra slumps, iron ore miners gain BHP faces a deadline today to decide on its bid for Anglo Amer...
Read ArticleMedAdvisor Solutions (ASX: MDR) is forecasting further strong growth over the next 12 months after a...
Read ArticleMedAdvisor guides the market to maiden profit MedAdvisor (ASX:MDR) jumped +15% this morning after pr...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleIf you're on the look at for some ASX dividend stocks to buy for your income portfolio, then you may...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleThe ASX200 closed .4 of a per cent up with IT and Health Care the locomotives of a sluggish steam en...
Read ArticleWhile the US economy is seen as a leading indicator for the world, the US Fed is unlikely to be the...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is pushing higher again. At the time of w...
Read ArticleThe Wesfarmers Ltd (ASX: WES) share price is treading water today on fresh acquisition rumours. S...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleMedAdvisor will pay £1 million (A$1.9 million) to UK pharmacy market app provider Charac Charac...
Read ArticleSo much for a small rise on the market today. Instead, the ASX200 closed down about three quarters (...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleAmplia reports positive data from pancreatic cancer trial Emyria was given endorsement by ethical c...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleThe ASX 200 benchmark falls 0.6% as we brace for news from The Fed Sector losses led by Resources,...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleASX is set to rise for a third consecutive day Tech stocks in the US rallied overnight after a soft...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleMoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleDespite the billions of dollars spent on developing new drugs, many of them are ineffective for a la...
Read ArticleMedadvisor [ASX:MDR], Australian developer of healthcare software for patients, announced its return...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleLittle joy for investors in December with traditional Christmas rally not eventuating in 2022 Meteo...
Read ArticleDecember winner Meteoric Resources sees a non-executive director buy 6 million shares Northern Sta...
Read ArticleOn Wednesday, the S&P/ASX 200 Index (ASX: XJO) was back on form and charged notably higher. T...
Read ArticleASX 200 gold shares soared on Wednesday, but could a ‘pivot point’ for the gold price be on the way...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) bounced back from yesterdayâs chaos today. The index closed...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has shaken off the malaise that has been gripping it this week...
Read ArticleASX 200 gold shares are having a top run on the market today amid higher gold prices. Gold explore...
Read ArticleInvestors were caught off guard yesterday after the Bank of Japan (BoJ) broke decades of monetary t...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has bounced back from yesterdayâs sello...
Read Article21 Dec 2022 - A snapshot of the stocks on the move featuring Matrix Composites & Engineering (AS...
Read ArticleThis content is created by Smallcaps Authors. [Author : Lorna Nicholas] MedAdvisor (ASX: MDR) has...
Read ArticleAn acquisitive couple of years is starting to pay off for pharmacy tech company MedAdvisor (ASX: MDR...
Read ArticleMarkets overnight were scrambling to adjust to a shock move by the Bank of Japan to allow the yield...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleASX healthcare shares have been a mixed bag this earnings season, with some names completely blowin...
Read ArticleMoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We...
Read ArticleASX 200 is flat Small Caps index is flatter, let’s call it tepid Lots of fun rumours to dissect ...
Read ArticleMedAdvisor (MDR) enters into a trading halt ahead of a $14.6 million capital raise to support accel...
Read ArticleHighlights: The S&P/ASX200 opened a little higher today (July 25). ASX 200 has been taking...
Read ArticleHighlights: The S&P/ASX200 opened a little higher today (July 25). ASX 200 has been taking...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleMedAdvisor (MDR) appoints US-based CEO and Managing Director, Rick Ratliff In April, current CEO a...
Read ArticleAntisense announces positive study of ATL1102 Acrux to launch a new product in the US MedAdvisor ge...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleMedAdvisor’s (MDR) CEO and Managing Director, Robert Read, intends to retire from his role as the c...
Read ArticleRhythm Biosciences releases positive results of ColoSTAT MedAdvisor’s acquisition Adheris exceeds r...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ASX 200 Health Index (XHJ) is trading higher by 0.27% at the time of writing, compared to the br...
Read ArticleMedtech company MedAdvisor (MDR) enters the New Zealand market via a three-year agreement with Gree...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleThe ASX 200 Health Index (XHJ) is down by 0.70% at the time of writing, compared to the broader inde...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleToday’s top stock was Playside Studios (ASX:PLY), the only ASX listed e-sports developer that’s base...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleSummary The ASX 200 dropped by 10.50 points or 0.14% to 7,406.90 by lunch. Barring materials, a...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleThe MedAdvisor Ltd (ASX: MDR) share price is on the rise today after the company announced a US bus...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleIt’s Thursday and who knew buying an Xbox was a bargain? Here’s the news from around the world. Tr...
Read ArticleThe ASX 200 managed to hold on to its lunchtime gains today, finishing the day higher by 0.43 per ce...
Read ArticleOn a day the ASX finished nearly 0.5 per cent up, tech stood alone in the red losing more than 2 per...
Read ArticleStockhead taps an extensive list of experts in Money Talks, our regular drill down into the stocks i...
Read ArticleThe MedAdvisor Ltd (ASX: MDR) share price is soaring today after the company announced an extension...
Read ArticleIn early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on form and pushing higher again....
Read ArticleGlobal stock markets dipped Stock markets dipped globally on fears over a potential third lockdown i...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleG’day gang, it’s Thursday already. Here’s your local and global tech news. Don’t forget to tune in f...
Read ArticleSummary MedAdvisor has experienced significant growth in the US after an acquisition, which was...
Read ArticleSummary In 2020, the stock market stayed highly volatile due to the negative impact of the coron...
Read ArticleFuture prospects of the health booking platform – 1st Group – with some new opportunities on the hor...
Read ArticleThe MedAdvisor Ltd (ASX: MDR) share price has been a positive performer on Monday morning. At the t...
Read ArticleThe MedAdvisor Ltd (ASX: MDR) share price is up 8.22% to 40 cents after the medtech company rele...
Read ArticleEarlier this week I looked at a couple of healthcare shares that have been tipped as potential mark...
Read ArticleIn afternoon trade the S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and i...
Read ArticleThe MedAdvisor Ltd (ASX: MDR) share price was a strong performer on Friday. The medication manageme...
Read ArticleMedical software group MedAdvisor (ASX: MDR) has come to the diagnosis that a discount may work bett...
Read ArticleThe MedAdvisor Ltd (ASX: MDR) share price will be one to watch later this week when it returns from...
Read ArticleMedical software group MedAdvisor (ASX: MDR) is prepared to massively dilute current shareholdings t...
Read ArticleShares in ASX-listed MedAdvisor have been placed in a trading halt today with the health-tech ventur...
Read ArticleIf you’re interested in gaining exposure to the small cap side of the market, I think it could be w...
Read ArticleMedical technology is a broad field covering areas like biotechnology, pharmaceuticals, and informa...
Read ArticleFortunes were to be made in ASX health stocks during March and April as investors looked for salvati...
Read ArticleThe Australian share market is home to a number of world class healthcare companies such as Ramsay...
Read ArticleRight now, I believe that are a number of small cap ASX shares that have the potential to grow into...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve bee...
Read ArticleDue to new technologies and favourable industry tailwinds, I think there are a number of small cap...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleOne area of the market that I think is a good place to look for buy and hold options is the small e...
Read ArticleWhen it comes to investing in world class healthcare companies, the Australian share market is home...
Read ArticleShares in MedAdvisor Limited (ASX:MDR), traded up to 10% higher on Monday after the company announce...
Read ArticleGlobal funding for telehealth companies surged in the March quarter as investors jumped on what will...
Read ArticleWorking from home was once an office perk. Now, after a month of everyone being forced to do...
Read ArticleFollowing the excellent analysis of how volatile March 2020 was for the Dow Jones Industrial Average...
Read Article2020 was looking good for many companies but COVID-19 changed all that. Some have needed capital to...
Read ArticleDigital medication management company MedAdvisor (ASX: MDR) will add a telehealth service to its onl...
Read ArticleThe MedAdvisor Ltd (ASX: MDR) share price has been on fire on Tuesday morning. At the time of writi...
Read ArticleASX-listed MedAdvisor has fast-tracked plans to launch an “Uber” for pharmacy delivery services as...
Read ArticleThe developer of a home delivery service for prescription medicines hopes to ease the burden placed...
Read ArticleAustralian-based MedAdvisor (ASX: MDR) will begin offering home delivery to customers as a way of re...
Read ArticleThe Medadvisor Ltd (ASX: MDR) share price has soared today after the digital medication management...
Read ArticleThe arrival of COVID-19 in Australia has led to government restrictions on travel and large social g...
Read ArticleThe Medadvisor Ltd (ASX: MDR) share price is surging higher today after the company provided an upd...
Read ArticleDigital medication management company MedAdvisor (ASX: MDR) has been endorsed by the UK’s National P...
Read ArticleThe MedAdvisor Ltd (ASX: MDR) share price is rocketing higher on Tuesday. In morning trade the lead...
Read ArticleThe Medadvisor Ltd (ASX: MDR) share price surged 13.92% higher today after the market reacted very...
Read ArticleThe medical technology sector is a fast-growing sector both domestically on the ASX and internation...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 134-odd small ca...
Read ArticleThe Medadvisor Ltd (ASX: MDR) share price was one of the best performers on the Australian share ma...
Read ArticleA momentary hiatus in US-China economic conflicts sent Wall Street to fresh records as phase one of...
Read ArticleMedAdvisor (MDR) has signed its second U.S. agreement to provide medication education programs for...
Read ArticleDigital medication management company MedAdvisor (ASX: MDR) has signed a second US agreement to prov...
Read ArticleDid the doc say to take one pill twice daily, or two tablets once daily? When it comes to correct me...
Read ArticleDigital medication company MedAdvisor (ASX: MDR) has further extended its operations within the grow...
Read Article07 Nov 2019 - MedAdvisor (ASX:MDR), Australia’s leading digital medication management company, has s...
Read ArticleMedication management tech company MedAdvisor (ASX:MDR) will begin a same-day medication delivery fu...
Read ArticleListed med-tech company MedAdvisor (ASX: MDR) has signed an agreement with one of Australia's leadin...
Read ArticleDigital medication management company MedAdvisor Ltd (ASX: MDR) last week announced it has raised $...
Read ArticleOn Stockhead today: the three biggest opportunities for digital transformation in pharma, why it’s t...
Read ArticleThe healthcare sector has been perhaps the slowest of all industries to embrace digitisation — and i...
Read ArticleAn $11 million investment from $4.4 billion US healthcare solutions provider HMS has sent shares in...
Read ArticleAustralian digital medication management company MedAdvisor (ASX: MDR) has secured a new cornerstone...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleOn Stockhead today: Aussie investors head over heels with these gas stocks, September’s top 50 miner...
Read ArticleCompanies and institutions that provide medical assistance and services, manufactures of medical equ...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
